The bone marrow niche and hematopoietic system are distinctly remodeled by CD45-targeted astatine-211 radioimmunotherapy.
Saved in:
| Title: | The bone marrow niche and hematopoietic system are distinctly remodeled by CD45-targeted astatine-211 radioimmunotherapy. |
|---|---|
| Authors: | Hagen MW; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA., Setiawan NJ; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA., Dexter S; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA., Woodruff KA; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA., Gaerlan FK; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA., Billings TM; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA., Orozco JJ; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA., Termini CM; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA. |
| Source: | Blood advances [Blood Adv] 2026 Apr 14; Vol. 10 (7), pp. 2452-2469. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
